These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis. Pucci N; Novembre E; Cianferoni A; Lombardi E; Bernardini R; Caputo R; Campa L; Vierucci A Ann Allergy Asthma Immunol; 2002 Sep; 89(3):298-303. PubMed ID: 12269651 [TBL] [Abstract][Full Text] [Related]
26. Topical ketorolac 0.5% solution for the treatment of vernal keratoconjunctivitis. Sharma A; Gupta R; Ram J; Gupta A Indian J Ophthalmol; 1997 Sep; 45(3):177-80. PubMed ID: 9475021 [TBL] [Abstract][Full Text] [Related]
27. Sodium cromoglycate ophthalmic solution as a Pharmacy Medicine for the management of mild-to-moderate, non-infectious inflammation of the conjunctiva in adults. Doughty MJ Ophthalmic Physiol Opt; 1996 Sep; 16 Suppl 2():S33-8. PubMed ID: 9398918 [No Abstract] [Full Text] [Related]
28. Ocular effects of long term use of topical steroids among children and adolescents with vernal keratoconjunctivitis: a prospective observational study. Mandal R; Maiti P; Sasmal NK; Sinha N; Gupta A; Das KS; Biswas MC J Indian Med Assoc; 2011 Oct; 109(10):708-10, 712-3. PubMed ID: 22482314 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of mipragoside ophthalmic gel in vernal keratoconjunctivitis. Centofanti M; Schiavone M; Lambiase A; Taffara M; Giuffrida S; Bonini S Eye (Lond); 1996; 10 ( Pt 4)():422-4. PubMed ID: 8944090 [TBL] [Abstract][Full Text] [Related]
30. [A prospective, observational, all-prescribed-patients study of cyclosporine 0.1% ophthalmic solution in the treatment of vernal keratoconjunctivitis]. Takamura E; Uchio E; Ebihara N; Okamoto S; Kumagai N; Shoji J; Nakagawa Y; Namba K; Fukushima A; Fujishima H; Miyazaki D; Ohashi Y Nippon Ganka Gakkai Zasshi; 2011 Jun; 115(6):508-15. PubMed ID: 21735754 [TBL] [Abstract][Full Text] [Related]
31. Topical ciclosporin in the treatment of vernal keratoconjunctivitis in Rwanda, Central Africa: a prospective, randomised, double-masked, controlled clinical trial. De Smedt S; Nkurikiye J; Fonteyne Y; Tuft S; De Bacquer D; Gilbert C; Kestelyn P Br J Ophthalmol; 2012 Mar; 96(3):323-8. PubMed ID: 22001151 [TBL] [Abstract][Full Text] [Related]
32. Single dose of ketotifen fumarate .025% vs 2 weeks of cromolyn sodium 4% for allergic conjunctivitis. Greiner JV; Michaelson C; McWhirter CL; Shams NB Adv Ther; 2002; 19(4):185-93. PubMed ID: 12431044 [TBL] [Abstract][Full Text] [Related]
33. A randomized trial of low-dose, topical mitomycin-C in the treatment of severe vernal keratoconjunctivitis. Akpek EK; Hasiripi H; Christen WG; Kalayci D Ophthalmology; 2000 Feb; 107(2):263-9. PubMed ID: 10690822 [TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of topical cyclosporine A 0.05% in vernal keratoconjunctivitis. Yücel OE; Ulus ND Singapore Med J; 2016 Sep; 57(9):507-10. PubMed ID: 26768065 [TBL] [Abstract][Full Text] [Related]
36. A double-masked study to compare the efficacy and safety of topical cromolyn for the treatment of allergic conjunctivitis. Liu YL; Hu FR; Wang IJ; Chen WL; Hou YC J Formos Med Assoc; 2011 Nov; 110(11):690-4. PubMed ID: 22118312 [TBL] [Abstract][Full Text] [Related]
37. Topical flurbiprofen therapy in vernal keratoconjunctivitis. Sud RN; Greval RS; Bajwa RS Indian J Med Sci; 1995 Sep; 49(9):205-9. PubMed ID: 8906937 [TBL] [Abstract][Full Text] [Related]
38. Topical bromfenac sodium for long-term management of vernal keratoconjunctivitis. Uchio E; Itoh Y; Kadonosono K Ophthalmologica; 2007; 221(3):153-8. PubMed ID: 17440276 [TBL] [Abstract][Full Text] [Related]
39. [Treatment of superficial lesions of the eye with sodium cromoglycate]. Verin P; Vildy A; Weisz L; Thiempont P; Tessier P Bull Soc Ophtalmol Fr; 1984 Oct; 84(10):1063-4. PubMed ID: 6443346 [No Abstract] [Full Text] [Related]